- Kentucky hospital adds inpatient MyChart platform
- 1 orthopedic surgeon on noncompetes, ASC equity deals and physician mobility
- 5 ASC leaders to watch
- New York hospital to add psychiatric emergency program
- How Sarasota Memorial unlocked 80+ inpatient beds daily without new construction
- FDA disputes estrogen patch shortage concerns
- U of Missouri opens $54.8M autism care facility
- What’s stopping pharmacists from practicing at the top of their license?
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Boston Scientific recalls pacemakers after 4 deaths, 2,500 injuries
- Accelerating priorities through co-designed precision quality improvement
- Rare bile duct cancer drug earns FDA approval
- CMS cuts funding for Texas psychiatric hospital
- HHS launches maternal health resource website
- FDA issues guidance for safe drug use during pregnancy
- Why new dentists must rethink private practice
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- Maine ophthalmology practice to close
- Carle Health approves Illinois outpatient expansion
- Munson Healthcare to open Michigan ASC
- U of Utah physician earns liver disease research grant
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Could autism care benefit from more therapy choices?
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Older Adults Have Fewer Regrets, Study Says
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Nighttime Heat Waves Increase Asthma Risk
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- Why Tenet’s CEO says ASCs keep choosing USPI
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
Pharmacy staff from CVS, Rite Aid, and Walgreens stores in US have started three-day walkout to protest harsh working conditions:
Pharmacy staff from CVS, Walgreens stores in US start three-day walkout
By Leroy Leo - October 30, 2023Oct 30 (Reuters) - Some employees at CVS Health Corp (CVS.N) and Walgreens Boots Alliance's (WBA.O) U.S. pharmacies launched a three-day walkout starting Monday to push the companies to improve working conditions and add more staff to their stores.
The walkout, which has been dubbed "Pharmageddon" on social media platforms such as Meta's Facebook where it was largely planned, started on Monday and led to the closing of some stores in New York City, two organizers told Reuters.
Shane Jerominski, a former Walgreens pharmacist and one of the organizers of the walkout, told Reuters that as many as 5,000 pharmacy workers would walk out across the three days, but said that the exact number of affected stores and participating staff was not clear due to the lack of a union.
He pointed to "grossly understaffed" stores where employees have to fill not only prescriptions but also look at appointments and walk-ins for immunization as one of the triggers for the action.
In September, some staff from CVS stores in Kansas City went on a two-day strike, while there was another by Walgreens store employees earlier this month.
Pharmacy staff in New York and Pennsylvania were planning to participate, including workers at some of Walgreens' Duane Reade stores in New York, he said.
Some pharmacists were also planning to conduct rallies outside CVS' headquarters at Woonsocket, Rhode Island and at Walgreens at Deerfield, Illinois, according to social media posts.
Jerominski said the organizers were also seeking better pay and more consistent hours for technicians, who locate, dispense, pack, and label prescribed medication for patients under the supervision of pharmacists.
In a bid to cut costs post a consolidation in the pharmacy industry, large companies have not employed enough pharmacists and technicians at the stores, leaving the staff overburdened, said John August, director of healthcare labor relations at Cornell University.
"The pandemic just caused so much additional work and stress that the turnover rates (of staff), which were already very high, just became extremely epidemic," he said.
The walkout is a sign of a new labor movement where people are organizing on their own without a union, August said, adding that such walkouts, even though legal, are risky because the staff "don't really have a traditional union to back them up in their strike."
A spokesperson for CVS said its leaders were connected with their pharmacists to directly address concerns and engaged in a "continuous two-way dialogue," while Walgreens said it has taken steps to help its pharmacy teams "concentrate on providing optimal patient care".
"Our ongoing efforts are focused on how we recruit, retain, and reward our pharmacy staff," a spokesperson for Walgreens told Reuters, adding that they have also centralized some operations to reduce pharmacists' workload.
The company earlier this month said it opened its 11th micro fulfillment center, which are centralized units that fill prescriptions, allowing its "staff to spend more time with customers" to offer other health-related products and services.
The walkouts are part of the larger trend of labor unrest in several industries, including strikes by autoworkers, writers and actors, as well as the largest recorded medical worker walkout by employees of Kaiser Permanente earlier this month.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















